Hepatitis b virus dna integration as a novel biomarker of hepatitis b virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis b virus cure

HIGHLIGHTS

• who: Romina Salpini1 and colleagues from the Nanjing Medical University, China have published the paper: Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure, in the Journal: (JOURNAL)
• what: By analyzing the whole exome of hepatocytes, this study has shown that HBV-DNA integration occurs not only in a notable proportion of patients with high HBV-DNA levels (55.6%), but also at significant frequency in patients with low (25%) and moderate viremia (14.3%), despite . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.